[The effects of two types of treatment on vital capacity, functional residual capacity and blood gases in idiopathic fibrosing alveolitis (author's transl)].
D000328:Adult; D000542:Alveolitis, Extrinsic Allergic / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D001784:Blood Gas Analysis; D004359:Drug Therapy, Combination; D005260:Female; D005652:Functional Residual Capacity; D006801:Humans; D008176:Lung Volume Measurements; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D014797:Vital Capacity
D011239:Prednisolone; D010396:Penicillamine; D001379:Azathioprine
Verlauf von Vitalkapazität, funktioneller Residualkapazität und Blutgasen unter zwei verschiedenen Behandlungsformen bei idiopathisch fibrosierender Alveolitis.